Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]

First targeted therapy for multiple myeloma effective against hard-to-treat...

Dr Torben Plesner - Vejle Hospital, Vejle, Denmark

First targeted therapy for multiple myeloma effective against hard-to-treat disease ( Dr Torben Plesner - Vejle Hospital, Vejle, Denmark )

First targeted therapy for genetically defined subset with acute myeloid...

Dr Richard Stone - Dana Farber Cancer Institute, Boston, USA

First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival ( Dr Richard Stone - Dana Farber Cancer Institute, Boston, USA )

Variants for increased risk of osteonecrosis in paediatric acute lymphocytic...

Dr Seth Karol - St Jude Children's Research Hospital, Tampa, USA

Variants for increased risk of osteonecrosis in paediatric acute lymphocytic leukaemia identified ( Dr Seth Karol - St Jude Children's Research Hospital, Tampa, USA )

Immunotherapy makes patients’ tumours "melt away"

Dr Joshua Brody - Mount Sinai Medical Center, New York, USA

Immunotherapy makes patients’ tumours "melt away" ( Dr Joshua Brody - Mount Sinai Medical Center, New York, USA )

Quality assessment looking at rivaroxaban for cancer-related thrombosis

Dr Gerald Soff - Memorial Sloan Kettering Cancer Center, New York, USA

Quality assessment looking at rivaroxaban for cancer-related thrombosis ( Dr Gerald Soff - Memorial Sloan Kettering Cancer Center, New York, USA )

Guidance for anticoagulation management in the setting of thrombocytopenia in...

Dr Gerald Soff - Memorial Sloan Kettering Cancer Center, New York, USA

Guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients ( Dr Gerald Soff - Memorial Sloan Kettering Cancer Center, New York, USA )

Genetic variant that signifies higher risk for avascular necrosis in children...

Dr Peter D. Cole - Albert Einstein College of Medicine, New York, USA

Genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia ( Dr Peter D. Cole - Albert Einstein College of Medicine, New York, USA )

Tosedostat for elderly acute myeloid leukaemia

Dr Giuseppe Visani - Ospedale S. Salvatore, Pesaro, Italy

Tosedostat for elderly acute myeloid leukaemia ( Dr Giuseppe Visani - Ospedale S. Salvatore, Pesaro, Italy )

Anti-Bcl2 therapy shows promise for relapsed/refractory multiple myeloma

Dr Shaji Kumar - Mayo Clinic, Rochester, USA

$Anti-Bcl2 therapy shows promise for relapsed/refractory multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )$

Daratumumab for multiple myeloma

Prof Sagar Lonial - Emory University School of Medicine, Atlanta, USA

Daratumumab for multiple myeloma ( Prof Sagar Lonial - Emory University School of Medicine, Atlanta, USA )

Research provides guidance for anticoagulation management in the setting of...

Dr Gerald A. Soff - Memorial Sloan Kettering Cancer Center, New York, USA

Research provides guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients ( Dr Gerald A. Soff - Memorial Sloan Kettering Cancer Center, New York, USA )

Promising new strategy for treating children with acute lymphocytic leukaemia

Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA

Promising new strategy for treating children with acute lymphocytic leukaemia ( Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA )

More from ecancer